◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksEXEL › Operating Income

Exelixis Inc (EXEL) Operating Income 2006–TTM

DATA UPDATED 2026-09-19

Exelixis Inc annual operating income for fiscal TTM was $971 million, an increase of 11.4% from $872 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

EXEL Annual Operating Income

Operating Income (annual)TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Operating Income (EBIT)$971M$872M$605M$171M$201M$287M$110M$369M$439M$166M($28M)($121M)($224M)($201M)($122M)$90M($91M)($122M)($179M)($157M)($127M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EXEL Quarterly Operating Income

Operating Income (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Operating Income (EBIT)$248M$251M$235M$237M$214M$187M$163M$136M$276M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Operating Income at Comparable Companies

More EXEL metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All EXEL financial statements → Interactive EXEL charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.